Results 101 to 110 of about 8,347 (150)

Paraneoplastic Endocrine Changes in Gastrointestinal Tumors: A Clinical and Mechanistic Review. [PDF]

Int J Mol Sci
Forțofoiu D, Sacerdoțianu VM, Șerban RE, Popa P, Dragne IG, Rogoveanu I, Boldeanu MV, Popescu DM, Vere CC.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Paraneoplastic neurological syndromes

Seminars in Diagnostic Pathology, 2019
Paraneoplastic neurological syndromes (PNS) constitute a heterogeneous group of cancer-related disorders that can affect any level of the central and peripheral nervous system. There is compelling evidence that PNS are caused by an immune response directed against neural antigens that are abnormally expressed by the tumour.
Iorio, Raffaele, Spagni, Gregorio, Masi, Gianvito   +2 more
openaire   +4 more sources

Neurological paraneoplastic syndromes

The Neuroscientist, 1996
Cancer arising outside of the nervous system (systemic cancer) often causes neurological disability without spreading to the nervous system [1] (Table 1). Such indirect or paraneoplastic effects of systemic cancer on the nervous system include vascular disorders (hemorrhages and/or infarction), infections, metabolic and nutritional disorders, as well ...
J, Dalmau, J B, Posner
openaire   +2 more sources

Paraneoplastic neurologic syndromes

Neurologic Clinics, 2003
Cancer can affect the nervous system through many metastatic and nonmetastatic mechanisms, including side effects of cancer treatment, infections, coagulopathy, and metabolic or nutritional deficits. Paraneoplastic neurologic disorders (PND) are an extensive group of syndromes that cannot be explained by any of these complications and may affect any ...
Luis, Bataller, Josep, Dalmau
openaire   +2 more sources

Paraneoplastic Neurologic Syndromes

Continuum, 2023
Progress is ongoing in understanding paraneoplastic neurologic disorders, with new syndromes and antibodies being described and more detailed evidence available to guide workup for diagnosis and treatment to improve outcomes. Many excellent reviews have summarized the molecular features of different antibodies, but this article emphasizes the clinical ...
openaire   +2 more sources

Neurological Paraneoplastic Syndromes

Cancer Investigation, 1988
(1988). Neurological Paraneoplastic Syndromes. Cancer Investigation: Vol. 6, No. 1, pp. 67-82.
D A, Chad, L D, Recht
openaire   +2 more sources

Paraneoplastic Neurologic Syndromes

Neurologic Clinics, 2008
Paraneoplastic neurologic syndromes (PNS) are mostly immune-mediated disorders that occur in patients with cancer. Because the same neurologic syndromes may occur without a cancer association it is important to know the likelihood of PNS, which is based in part on the syndrome and the patient's demographics and risk factors for cancer.
Myrna R, Rosenfeld, Josep, Dalmau
openaire   +2 more sources

Neurologic paraneoplastic syndromes

Journal of the Neurological Sciences, 1998
Several neurologic paraneoplastic disorders are believed to be caused by an autoimmune reaction against antigen(s) co-expressed by tumour cells and neurons. Of the paraneoplastic syndromes, the evidence for an autoimmune etiology is strongest for the Lambert-Eaton myasthenic syndrome, in which autoantibodies downregulate voltage-gated calcium channels ...
openaire   +3 more sources

Paraneoplastic Neurological Syndromes

2015
Marco Zoccarato, Luigi Zuliani, Bruno Giometto   +2 more
exaly   +2 more sources